SCHEMBL25211575

SCHEMBL25211575

CN(N)C(=O)c1ccccc1Cl

nearest known ligand 0.62

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.62
HPGD P15428 1/20 0.54
TSHR P16473 1/20 0.54
CES2 O00748 1/20 0.54
CES1 P23141 1/20 0.54
TP53 P04637 1/20 0.53
ALDH1A1 P00352 3/20 0.52
P2RX7 Q99572 1/20 0.48
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11254075 0.83 CES2 (0.58) POLBHPGDTSHRCES2CES1
SCHEMBL255022 0.83 POLB (0.67) POLBHPGDTSHRCES2CES1
SCHEMBL29482203 0.83 POLB (0.67) POLBHPGDTSHRCES2CES1
SCHEMBL7654141 0.82 POLB (0.65) POLBHPGDTSHRCES2CES1
SCHEMBL9782204 0.81 POLB (0.59) POLBHPGDTSHRCES2CES1
SCHEMBL11455792 0.81 POLB (0.59) POLBHPGDTSHRCES2CES1
SCHEMBL11375658 0.80 POLB (0.58) POLBHPGDTSHRCES2CES1
SCHEMBL28195080 0.80 CES2 (0.54) POLBHPGDTSHRCES2CES1
SCHEMBL27807210 0.79 TP53 (0.61) POLBHPGDTSHRCES2CES1
SCHEMBL11212458 0.78 POLB (0.61) POLBHPGDTSHRCES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023097386-A1 SELECTIVE HDAC6-INHIBITING N-ACYLHYDRAZONE COMPOUNDS, METHODS FOR PRODUCING SAME, COMPOSITIONS, USES, TREATMENT METHODS AND KITS EUROFARMA LABORATÓRIOS S.A (BR) 2023-06-08 WO disclosed
WO-2023097386-A1 SELECTIVE HDAC6-INHIBITING N-ACYLHYDRAZONE COMPOUNDS, METHODS FOR PRODUCING SAME, COMPOSITIONS, USES, TREATMENT METHODS AND KITS EUROFARMA LABORATÓRIOS S.A (BR) 2023-06-08 WO disclosed